General Information of the Compound
Compound ID
CP0420066
Compound Name
4-[4-(2-phenylethyl)piperazin-1-yl]-5-propan-2-ylpyrrolo[3,2-d]pyrimidine-7-carbonitrile
    Show/Hide
Structure
Formula
C22H26N6
Molecular Weight
374.492
Canonical SMILES
CC(C)n1cc(C#N)c2ncnc(N3CCN(CCc4ccccc4)CC3)c12
    Show/Hide
InChI
InChI=1S/C22H26N6/c1-17(2)28-15-19(14-23)20-21(28)22(25-16-24-20)27-12-10-26(11-13-27)9-8-18-6-4-3-5-7-18/h3-7,15-17H,8-13H2,1-2H3
    Show/Hide
InChIKey
GBQUDWSZESXSJW-UHFFFAOYSA-N
Physicochemical Property
logP
3.24858
Rotatable Bonds
5
Heavy Atom Count
28
Polar Areas
60.98
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127051982
ChEMBL ID
CHEMBL3806249
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02516, Multidrug resistance-associated protein 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000348 H69AR Homo sapiens (Human)  2
1
IC50 = 821 nM
   TI
   LI
   LO
   TS
2
IC50 = 1240 nM
   TI
   LI
   LO
   TS